X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (166) 166
Newspaper Article (84) 84
Publication (45) 45
Book / eBook (36) 36
Book Review (6) 6
Dissertation (4) 4
Book Chapter (3) 3
Magazine Article (3) 3
Conference Proceeding (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (68) 68
index medicus (56) 56
middle aged (50) 50
male (48) 48
female (44) 44
adult (39) 39
hematology (39) 39
article (32) 32
aged (31) 31
transplantation (23) 23
treatment outcome (23) 23
oncology (22) 22
cyclophosphamide (21) 21
stem-cell transplantation (15) 15
analysis (14) 14
bone marrow (14) 14
immunology (14) 14
young adult (14) 14
versus-host-disease (13) 13
acute myeloid-leukemia (12) 12
cyclophosphamide - administration & dosage (12) 12
adolescent (11) 11
bone-marrow-transplantation (11) 11
cyclophosphamide - therapeutic use (11) 11
hematology, oncology and palliative medicine (11) 11
leukemia (11) 11
mortality (11) 11
remission induction (11) 11
retrospective studies (11) 11
therapy (11) 11
t cells (10) 10
antineoplastic combined chemotherapy protocols - therapeutic use (9) 9
cancer (9) 9
disease (9) 9
dose-response relationship, drug (9) 9
medical colleges (9) 9
abridged index medicus (8) 8
antineoplastic combined chemotherapy protocols - adverse effects (8) 8
care and treatment (8) 8
cyclophosphamide - adverse effects (8) 8
disease-free survival (8) 8
haploidentical (8) 8
hematologic malignancies (8) 8
hemic and lymphatic diseases (8) 8
history (8) 8
immunosuppressive agents - therapeutic use (8) 8
patients (8) 8
rituximab (8) 8
surgical procedures, operative (8) 8
transplantation, homologous (8) 8
child (7) 7
drug administration schedule (7) 7
high-dose cyclophosphamide (7) 7
immune system diseases (7) 7
research (7) 7
bone marrow transplantation - methods (6) 6
clinical neurology (6) 6
combined modality therapy (6) 6
follow-up studies (6) 6
graft vs host disease - prevention & control (6) 6
kaplan-meier estimate (6) 6
medicine & public health (6) 6
multiple sclerosis (6) 6
natural sciences (6) 6
naturvetenskap (6) 6
post-transplant cyclophosphamide (6) 6
recurrence (6) 6
risk factors (6) 6
survival (6) 6
usage (6) 6
acute myelogenous leukemia (5) 5
antineoplastic agents - therapeutic use (5) 5
antineoplastic combined chemotherapy protocols - administration & dosage (5) 5
biological sciences (5) 5
blood (5) 5
bone marrow transplantation (5) 5
bone marrow transplantation - adverse effects (5) 5
chemical and pharmacologic phenomena (5) 5
chemotherapy (5) 5
child, preschool (5) 5
follow-up (5) 5
graft vs host disease - mortality (5) 5
great britain (5) 5
histocompatibility testing (5) 5
hla antigens - immunology (5) 5
immunosuppressive agents - administration & dosage (5) 5
leukemia, myeloid, acute - drug therapy (5) 5
neutropenia - chemically induced (5) 5
pediatrics (5) 5
posttransplantation cyclophosphamide (5) 5
prophylaxis (5) 5
prospective studies (5) 5
remission (5) 5
rheumatology (5) 5
risk (5) 5
speciation (5) 5
surgery (5) 5
survival analysis (5) 5
taxonomy (5) 5
transplantation conditioning (5) 5
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (18) 18
UTL at Downsview - May be requested (7) 7
Victoria University E.J. Pratt - Stacks (6) 6
Online Resources - Online (4) 4
St. Michael's College (John M. Kelly) - 2nd Floor (4) 4
Trinity College (John W Graham) - Storage (3) 3
Engineering & Comp. Sci. - Stacks (2) 2
Royal Ontario Museum - Stacks (2) 2
Thomas Fisher Rare Book - Rare Book (2) 2
Trinity College (John W Graham) - Stacks (2) 2
UofT at Scarborough - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Gerstein Science - Stacks (1) 1
Indust. Rel's & Hum. Resources (Newman) - Library use only (1) 1
Robarts - Storage (1) 1
University College (Laidlaw) - Stacks (1) 1
UofT at Mississauga - Reference (1) 1
UofT at Mississauga - Stacks (1) 1
Victoria University CRRS - Library use only (1) 1
Victoria University E.J. Pratt - Canadiana (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 3342 - 3342
INTRODUCTION: Allogeneic blood or marrow transplant (alloBMT) is widely used in relapsed/refractory systemic non-Hodgkin lymphoma. The graft-versus-tumor... 
Journal Article
Hematology, ISSN 1520-4391, 12/2017, Volume 2017, Issue 1, pp. 645 - 650
Abstract Allogenic hematopoietic stem cell recipients may have preformed antibodies directed against foreign HLA antigens. The use of partially HLA-mismatched... 
Journal Article
Human Immunology, ISSN 0198-8859, 10/2018, Volume 79, pp. 35 - 35
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/j.humimm.2018.07.035... 
Antigen-antibody reactions | Immunogenetics | Histocompatibility antigens | Analysis | HLA histocompatibility antigens | Stem cells | Monoclonal antibodies | Transplantation | B cells | T cells
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 03/2018, Volume 24, Issue 3, pp. S420 - S421
Journal Article
Hematology. American Society of Hematology. Education Program, ISSN 1520-4391, 12/2017, Volume 2017, Issue 1, pp. 645 - 650
Allogenic hematopoietic stem cell recipients may have preformed antibodies directed against foreign HLA antigens. The use of partially HLA-mismatched... 
Therapeutic Apheresis as an Immunomodulatory Tool
Journal Article
Blood, ISSN 0006-4971, 05/2015, Volume 125, Issue 19, pp. 3024 - 3031
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2015, Volume 33, Issue 28, pp. 3152 - 3161
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 02/2017, Volume 23, Issue 3, pp. 697 - 706
Purpose: In preclinical studies, the PARP inhibitor veliparib enhanced the antileukemic action of temozolomide through potentiation of DNA damage. Accordingly,... 
POLY(ADP-RIBOSE) POLYMERASE | CELLS | REPAIR | THERAPY | HUMAN PLASMA | ONCOLOGY | DNA-DAMAGE | ABT-888 | ADULTS | HOMOLOGOUS RECOMBINATION | TUMORS | Dacarbazine - adverse effects | Humans | Middle Aged | DNA Repair Enzymes - genetics | Esophagitis - chemically induced | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Neoplasm Proteins - antagonists & inhibitors | Promoter Regions, Genetic - drug effects | Leukemia, Myelomonocytic, Chronic - drug therapy | Promoter Regions, Genetic - genetics | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Young Adult | Benzimidazoles - administration & dosage | Protein Processing, Post-Translational - drug effects | Dacarbazine - pharmacology | Tumor Suppressor Proteins - genetics | Dacarbazine - analogs & derivatives | Aged, 80 and over | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Phosphorylation - drug effects | Benzimidazoles - adverse effects | Poly (ADP-Ribose) Polymerase-1 - analysis | Dacarbazine - administration & dosage | Kaplan-Meier Estimate | Poly(ADP-ribose) Polymerase Inhibitors - adverse effects | Remission Induction | Mucositis - chemically induced | Poly(ADP-ribose) Polymerase Inhibitors - administration & dosage | Drug Synergism | Poly(ADP-ribose) Polymerase Inhibitors - pharmacology | DNA Modification Methylases - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Benzimidazoles - pharmacology | Neoplasm Proteins - analysis | Aged | Histones - metabolism | Temozolomide | DNA Methylation - drug effects | Potentiation | Phosphorylation | Toxicity | Leukemia | DNA damage | Poly(ADP-ribose) | ADP | Anticancer properties | Ribose | DNA methylation | Pretreatment | Polymers | Deoxyribonucleic acid--DNA | CD34 antigen | Pharmacodynamics | Mucositis | Anemia | Myeloid leukemia | Esophagitis | Poly(ADP-ribose) polymerase | Pharmacology | Fanconi syndrome | Patients | Poly(ADP-ribose) Polymerase 1 | Inhibitors | Experimental design | Methylation | Pharmacokinetics | Acute myeloid leukemia | Cancer | temozolomide | veliparib | acute myeloid leukemia | DNA repair | PARP inhibition
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 25, pp. 3817 - 3827
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 02/2017, Volume 23, Issue 4, pp. 899 - 907
Purpose: The PARP inhibitor veliparib delays DNA repair and potentiates cytotoxicity of multiple classes of chemotherapy drugs, including topoisomerase I... 
TRANSFORMATION | CELLS | REPAIR | ONCOLOGY | RECOMMENDATIONS | BONE-MARROW | ABT-888 | MUTATION | ACUTE MYELOID-LEUKEMIA | CANCER | POLY(ADP-RIBOSE) POLYMERASE INHIBITOR | Fanconi Anemia Complementation Group D2 Protein - genetics | Humans | Leukemia, Myelomonocytic, Chronic - genetics | Middle Aged | Male | Carboplatin - pharmacokinetics | Leukemia, Myelomonocytic, Chronic - drug therapy | Drug-Related Side Effects and Adverse Reactions - pathology | Carboplatin - adverse effects | Dose-Response Relationship, Drug | Benzimidazoles - administration & dosage | Adult | Female | Leukemia, Myelomonocytic, Chronic - pathology | Benzimidazoles - adverse effects | Leukemia, Biphenotypic, Acute - drug therapy | Benzimidazoles - pharmacokinetics | Carboplatin - administration & dosage | Topotecan - adverse effects | Myeloproliferative Disorders - drug therapy | Poly (ADP-Ribose) Polymerase-1 - antagonists & inhibitors | Disease-Free Survival | Topotecan - pharmacokinetics | Topotecan - administration & dosage | Aged | Poly (ADP-Ribose) Polymerase-1 - genetics | Drugs | Phosphorylation | Histone H2A | Toxicity | Leukemia | DNA damage | Cytotoxicity | Dosage | DNA repair | Neoplasms | Confidence intervals | Infusion | Ubiquitination | Chronic myelomonocytic leukemia | Repair | Deoxyribonucleic acid--DNA | CD34 antigen | Myelomonocytic leukemia | Mucositis | DNA topoisomerase | Poly(ADP-ribose) polymerase | Topotecan | Patients | Chemotherapy | Inhibitors | Experimental design | Carboplatin | Auditory defects | Cancer | Tumors
Journal Article
Haematologica, ISSN 0390-6078, 2017, Volume 102, Issue 2, pp. 391 - 400
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 3841 - 3841
Background: Patients with acute myeloid leukemia (AML) presenting with hyperleukocytosis have frequent complications and early mortality. Pulmonary, central... 
Journal Article
Haematologica, ISSN 0390-6078, 11/2012, Volume 97, Issue 11, pp. 1736 - 1742
Journal Article
Leukemia, ISSN 0887-6924, 08/2018, Volume 32, Issue 8, pp. 1768 - 1777
Journal Article